Per Olsson Gisleskog
Per Olsson Gisleskog is a Principal Consultant and one of the founders of Exprimo. He was born in 1960 in Sweden. Per obtained his M.Sc. in pharmacy and his PhD from the University of Uppsala, his PhD focused on population PK/PD modelling. He initially worked within pharmaceutical development and pharmacokinetics at Pharmacia in Sweden. Thereafter, he worked for Glaxo/GSK in the UK, where he held several positions within the Clinical Pharmacology division, being responsible for pharmacokinetics, population pharmacokinetics, modelling and simulation in several therapeutic areas. He was also appointed clinical development team leader. Prior to joining Exprimo Per worked for Pharsight, where he was a scientific consultant, working with modelling of pharmacokinetics, pharmacodynamics and clinical endpoints, and clinical trial simulation. He has over 15 years experience of pharmaceutical drug development and more than 10 years consultancy experience. He is author of several original research papers in the fields of pharmacokinetic/pharmacodynamic modelling. His current research interests focus around the use of modelling and simulation approaches to provide a rational basis for decision making in drug development. Per lives in the UK.